GMP IPO
📋 Filings Intelligence
About Contact
LIVE - Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement - financial results, order wins, dividends, mergers and more. Updated live.

-
Filed today
-
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings -

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Asston Pharmaceuticals Ltd

Asston Pharmaceuticals Board Meeting to Approve Q2 FY27 Unaudited Financials

RESULTS ● No Immediate Change LOW RISK
📅 Filed on BSE: 05 Nov 2026, 05:39 PM IST  ·  BSE ID: 949a7ba4-a043-4124-beeb-b2d5923ad157
View Original BSE Filing (PDF)
💡
In Simple Terms
Asston Pharmaceuticals is holding a board meeting on November 12, 2026, to approve its half-yearly financial results.
🤖 AI Summary
  • Asston Pharmaceuticals Board meeting scheduled for Thursday, November 12, 2026.
  • Meeting to consider and approve Unaudited Financial Statements for half-year ended September 30, 2026.
  • A limited review report for the half-year ended September 30, 2026, will also be approved.
  • Other incidental matters will be discussed during the Board meeting proceedings.
👥 What This Means For Shareholders
✅
Action Required
No immediate action is required by shareholders.
👤
Who Is Affected
All shareholders are equally affected as this is a standard corporate governance update regarding the upcoming financial results approval.
🔍
Management Signal
The scheduling of the Board meeting signals management's adherence to regulatory timelines for financial reporting under Regulation 29(1) of SEBI Listing Regulations.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List - track these upcoming events
Outcome of Board Meeting on November 12, 2026 — for Q2 FY27 financial results.
Disclosure of Unaudited Financial Statements for half-year ended September 30, 2026.
Review of commentary accompanying the Q2 FY27 financial results post-meeting.
LOW RISK The filing is a routine Board Meeting intimation for financial results approval.
💡 Investor Takeaway
Asston Pharmaceuticals will hold a Board meeting on November 12, 2026, to approve its Unaudited Financial Statements for the half-year ended September 30, 2026 (Q2 FY27). The outcome will include a limited review report.
📅 Company Track Record
Asston Pharmaceuticals Limited was incorporated in 2019 (CIN: U24304MH2019PLC324187) and was formerly known as Asston Pharmaceuticals Private Limited. No previous filings are available for context on financial performance or corporate actions.

Based on publicly available historical data. For context only.

❓ Frequently Asked Questions
When is the Board Meeting for Asston Pharmaceuticals scheduled?
The Board of Directors meeting for Asston Pharmaceuticals is scheduled for Thursday, November 12, 2026.
What financial statements will be considered at Asston Pharmaceuticals' Board Meeting?
The Board will consider and approve the Unaudited Financial Statements along with a limited review report for the half-year ended September 30, 2026.
What regulation governs this Board Meeting intimation by Asston Pharmaceuticals?
This intimation is made pursuant to Regulation 29(1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Questions based on this BSE filing only. For information purposes.

You've read one filing

There are 32,000 more, and one of them is about a company you own

Follow a company and we'll email you the moment it files again - explained, not just forwarded. Free.

  • Follow companies and get filings by email
  • Save any filing to read later
  • Two full AI analyses every month, free

No card needed. Sign in with Google in two taps.

⚠️ For Information Only - Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector - takes 5 seconds.